Correction: Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction: Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges ; volume:12 ; number:1 ; day:9 ; month:10 ; year:2023 ; pages:1-3 ; date:12.2023
Cell Regeneration ; 12, Heft 1 (9.10.2023), 1-3, 12.2023
- Creator
-
Zheng, Haiqiong
Chen, Yijin
Luo, Qian
Zhang, Jie
Huang, Mengmeng
Xu, Yulin
Huo, Dawei
Shan, Wei
Tie, Ruxiu
Zhang, Meng
Qian, Pengxu
Huang, He
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13619-023-00177-4
- URN
-
urn:nbn:de:101:1-2024020907422114250133
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zheng, Haiqiong
- Chen, Yijin
- Luo, Qian
- Zhang, Jie
- Huang, Mengmeng
- Xu, Yulin
- Huo, Dawei
- Shan, Wei
- Tie, Ruxiu
- Zhang, Meng
- Qian, Pengxu
- Huang, He
- SpringerLink (Online service)
Other Objects (12)
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Engineering better chimeric antigen receptor T cells
The crystal structure of (2 R, 6′ R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3 H -spiro (benzofuran-2,1′-cyclohexan)-2′-ene-3,4′-dione, C 16 H 14 Cl 2 O 5
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Organic fluorescent probes for live-cell super-resolution imaging
Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Engineering better chimeric antigen receptor T cells
The crystal structure of (2 R, 6′ R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3 H -spiro (benzofuran-2,1′-cyclohexan)-2′-ene-3,4′-dione, C 16 H 14 Cl 2 O 5
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Organic fluorescent probes for live-cell super-resolution imaging
Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Engineering better chimeric antigen receptor T cells
The crystal structure of (2 R, 6′ R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3 H -spiro (benzofuran-2,1′-cyclohexan)-2′-ene-3,4′-dione, C 16 H 14 Cl 2 O 5
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Organic fluorescent probes for live-cell super-resolution imaging